Press release
Multiple Myeloma Market is expected to reach US$ 34.58 billion by 2032 | Emerging key players - GSK plc, Takeda Pharmaceutical Company Limited, Poseida Therapeutics.
Multiple Myeloma Market
The Global Multiple Myeloma Market size reached US$ 22.3 billion in 2024 and is expected to reach US$ 34.58 billion by 2032, growing at a CAGR of 5.6% during the forecast period 2025-2032.
Multiple Myeloma Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/multiple-myeloma-market?sz
The Multiple Myeloma Market refers to the global industry focused on the research, development, manufacturing, and commercialization of therapies for multiple myeloma, a cancer of plasma cells. It includes pharmaceuticals, biologics, diagnostics, and supportive treatments aimed at improving patient outcomes, survival rates, and quality of life, driven by innovations in immunotherapy, targeted therapy, and personalized medicine.
Recent Key Developments of USA and Japan:
USA:
July 2, 2025: FDA grants accelerated approval to linvoseltamab (Lynozyfic) for relapsed/refractory multiple myeloma (MM) after four or more prior lines of therapy.
July 30, 2025: The FDA grants Orphan Drug Designation to SAR446523 for the treatment of relapsed/refractory MM.
Japan:
May 19, 2025: Japan's Ministry of Health, Labour and Welfare (MHLW) approves GSK's Blenrep (belantamab mafodotin) combinations for adults with relapsed or refractory MM who have received at least one prior therapy.
February 25, 2025: The MHLW in Japan approves Sarclisa (isatuximab) in combination with bortezomib, lenalidomide, and dexamethasone for newly diagnosed MM patients.
Market Key Players:
Amgen Inc.
Sanofi
Novartis AG
Teva Pharmaceutical Industries Ltd.
Johnson & Johnson Services, Inc.
Bristol-Myers Squibb Company
ONO PHARMACEUTICAL CO., LTD.
Pfizer Inc.
Karyopharm
Amneal Pharmaceuticals LLC.
Emerging Market Players:
GSK plc
Takeda Pharmaceutical Company Limited
Poseida Therapeutics
Regeneron Pharmaceuticals, Inc.
Genentech, Inc.
Growth Forecast Projected:
The Global Multiple Myeloma Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Multiple Myeloma Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=multiple-myeloma-market
Market Segmentation:
By Type: Smoldering (Indolent) Multiple Myeloma, Active (Symptomatic) Multiple Myeloma.
By Treatment: Chemotherapy, Immunotherapy, Radiation, Stem Cell Transplant, Targeted Therapy.
By End-User: Hospitals, Cancer Centers, Others.
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/multiple-myeloma-market
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
People Also Ask:
➠ How big is the Multiple Myeloma market?
➠ Who are the key players in the Multiple Myeloma market?
➠ What is the projected growth rate of the Multiple Myeloma market?
➠ What is the market forecast for the Multiple Myeloma industry by 2033?
➠ Which region is estimated to dominate the Multiple Myeloma market through the forecast period?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Multiple Myeloma Market is expected to reach US$ 34.58 billion by 2032 | Emerging key players - GSK plc, Takeda Pharmaceutical Company Limited, Poseida Therapeutics. here
News-ID: 4171792 • Views: …
More Releases from DataM Intelligence 4Market Research
Electroencephalography Devices Market is expected to reach US$ 3.08 billion by 2 …
Market Size and Growth:
The Electroencephalography Devices Market size reached US$ 1.48 billion in 2023 and is expected to reach US$ 3.08 billion by 2033, growing at a CAGR of 7.4% during the forecast period 2025-2033.
Electroencephalography Devices Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and…
Electronic Clinical Outcome Assessment Solutions Market is expected to reach US$ …
Market Size and Growth:
The Global Electronic Clinical Outcome Assessment Solutions Market size reached US$ 1.93 Billion in 2024 from US$ 1.67 Billion in 2023 and is expected to reach US$ 7.93 Billion by 2033, growing at a CAGR of 17.1% during the forecast period 2025-2033.
Electronic Clinical Outcome Assessment Solutions Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed…
Intrauterine Contraceptive Devices (IUD) Market is expected to reach US$ 6.92 Bi …
Market Size and Growth:
The Intrauterine Contraceptive Devices (IUD) Market size reached US$ 4.56 Billion in 2024 and is expected to reach US$ 6.92 Billion by 2033, growing at a CAGR of 4.8% during the forecast period 2025-2033.
Intrauterine Contraceptive Devices Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make…
Japan Remote Patient Monitoring Market is expected to reach US$ 3,536.54 million …
Market Size and Growth:
The Japan Remote Patient Monitoring Market reached US$ 470.56 million in 2024 and is expected to reach US$ 3,536.54 million by 2033, growing at a CAGR of 24.9% during the forecast period 2025-2033.
Japan Remote Patient Monitoring Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make…
More Releases for Multiple
Mango AI's Multiple Face Swap Video Tool Changes Multiple Faces Instantly
In today's digital world, creating eye-catching and unique content is essential for standing out. The ability to swap multiple faces in a single video opens up creative possibilities, whether for personalized content, comedy or parody videos, or engaging social media posts. Mango AI, developed by Mango Animate, is excited to announce the launch of its advanced multiple face swap video (https://mangoanimate.com/ai/multiple-face-swap-video) tool, which is designed to simplify the creation of…
Multiple Sclerosis Drugs Market
Global Multiple Sclerosis Drugs Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market.
Get a Sample Copy of the Report at - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/100386
Multiple Sclerosis (MS) is an immune-mediated disease affecting the central nervous system. It is characterized by demyelination, inflammation, degenerative changes such as progressive brain and spinal cord atrophy and neuroaxonal…
Massive Multiple Input Multiple Output (MIMO) Market May Set New Growth Story
A Latest intelligence report published by MR Forecast with title "Global Massive Multiple Input Multiple Output (MIMO) Market Outlook to 2032. A detailed study accumulated to offer Latest insights about acute features of the Massive Multiple Input Multiple Output (MIMO) market. This report provides a detailed overview of key factors in the Global Massive Multiple Input Multiple Output (MIMO) Market and factors such as driver, restraint, past and current trends,…
Multiple Sclerosis Drugs Market - Progressing Towards a Cure: Advancing Multiple …
Newark, New Castle, USA: The "Multiple Sclerosis Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Multiple Sclerosis Drugs Market: https://www.growthplusreports.com/report/multiple-sclerosis-drugs-market/7983
This latest report researches the industry structure,…
Multiple Sclerosis Drugs Market - Empowering Resilience, Embracing Possibilities …
Newark, New Castle, USA - new report, titled Multiple Sclerosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Multiple Sclerosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Multiple Sclerosis Drugs market. The report offers an overview of…
Massive MIMO (Multiple-input multiple-output) Market 2022-2028 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Massive MIMO (Multiple-input multiple-output) industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Massive MIMO (Multiple-input multiple-output) market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Massive MIMO (Multiple-input multiple-output)…
